Geistlich Pharma AG – General Planning of Cleanroom Buildings for Medical Technology
Geistlich Pharma AG is the global market leader in regenerative dentistry. IE Life Science was responsible for the Planning and Execution of a new industrial building with multiple cleanroom systems to expand GMP‑compliant production capacity.
Closer to the Market Through Flexible Production
Project
General planning and Planning and Execution of a production building with multiple cleanroom systems, integrated into the existing facility.
Client
Geistlich Pharma AG
Key Data
Working Together for Project Success
Services provided by IE Group
- Concept and system planning
- General planning
- Planning and coordination of construction activities
- Flexible and expandable production infrastructure
- Capacity increase for current and future GMP products
- Assurance of high cleanroom and cGMP requirements
- Support for efficient bulk production and optimal access to highly installed cleanrooms
Challenges & Solutions
Seamless integration of a new cleanroom building into an existing production infrastructure
Scalable cleanroom technology for growing GMP production capacities
The Project in Detail
Geistlich Pharma AG is one of Switzerland’s oldest family‑owned companies and a global leader in regenerative dentistry. At the Wolhusen site, biomaterials are developed and produced for international markets, distributed through eleven subsidiaries and more than 60 partners worldwide. To support further growth, particularly for global markets, GMP production capacity had to be expanded. IE Life Science was commissioned with the general planning of a new industrial building featuring multiple cleanroom systems, directly connected to the existing factory infrastructure.
The Challenge
The key challenge was to expand GMP‑compliant production while integrating a new cleanroom building seamlessly into the existing manufacturing infrastructure. This required a planning approach that combined in‑depth cleanroom expertise, comprehensive GMP knowledge and strong interdisciplinary coordination. IE Life Science therefore developed the industrial building concept consistently from the inside out. Only after a thorough analysis and planning of operational processes were the architectural layout and building structure defined. This ensured that the new cleanroom building could be connected to the existing facility without disrupting ongoing operations and while preserving future expansion options. A further challenge was to create a production infrastructure that could grow with future requirements. Through a modular cleanroom and building services concept, scalable cleanroom technology was implemented, allowing capacity to be increased step by step as demand grows. This forward‑looking approach ensures long‑term flexibility and investment security for Geistlich Pharma AG while maintaining the highest GMP standards.
Key Success factors
Planning followed the inside‑out principle. Operational processes and GMP requirements defined the layout, zoning and technical infrastructure before the building structure was developed. Modular cleanroom concepts and centrally accessible building services ensure long‑term flexibility, simplified maintenance and scalable expansion. Additional cleanroom levels created reserve capacity for future growth while maintaining full cGMP compliance.
Deepen Your Knowledge
Discover further details in our Project Insight.